SH

Shahram Hejazi

Venture Capital Investor | Princeton Faculty | Entrepreneur | Global CEO

Princeton, New Jersey

Invests in

  • Min Investment:

    $1,500,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $3,250,000.00

Work Experience

  • Managing Director & CEO

    2008

    BioAdvance is a 22-year-old venture capital firm specializing in early-stage investments across biotech, digital health, diagnostics, and medical devices, with a portfolio of over 120 companies since inception. Joined the firm as a Partner and was appointed Managing Director & CEO in October 2021. In this role, responsible for overall leadership and strategic direction, as well as leading select investments. Currently serve on the Board of Directors for several portfolio companies, including BainBridge, Keriton, Halo Labs, Talex Medical, and Wellsheet.

  • Faculty and Head of Entrepreneurship

    2014

    Began as the 2014 James Wei Professor of Entrepreneurship and currently a Faculty and Head of the Entrepreneurship Program, teaching two high-level courses in Entrepreneurship and Venture Capital/Finance of Innovation. The courses which often receive Dean's recognition for Teaching Excellence, are also part of Minor Programs in Entrepreneurship, Finance, and Technology & Society. Lead the development of the Entrepreneurship Curriculum and the Entrepreneurship Program.

  • Founder and CEO

    2019

    A venture-backed non-viral in vivo gene therapy company based on a transformative polymeric (non-lipid based) platform exclusively licensed from Princeton University.

2008 - 2008

  • Entrepreneur In Residence

    2008 - 2008

  • President

    2004 - 2008

  • Global Head of Strategic Business Development

    1996 - 2001